Microsoft said it would invest $1.5 billion in G42, an Emirati company with ties to China, as Washington and Beijing maneuver to secure tech influence in the Persian Gulf.
Tag: Intellectual Property
Indigenous Authors and the Challenge of Telling Their Own Story
A university program seeks to improve cross-cultural understanding in Australia’s publishing industry.
Her Instagram Handle Was ‘Metaverse.’ Last Month, It Vanished.
Five days after Facebook changed its name to Meta, an Australian artist found herself blocked, with seemingly no recourse, from an account documenting nearly a decade of her life and work.
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.
As U.S. Hunts for Chinese Spies, University Scientists Warn of Backlash
A chilling effect has taken hold on American campuses, contributing to an outflow of academic talent that may hurt the United States while benefiting Beijing.
Pressure Grows on U.S. Companies to Share Covid Vaccine Technology
Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company to license its technology.
U.S. Moves to Drop Cases Against Chinese Researchers
The arrests were part of a Trump-era initiative aimed at curbing Beijing’s efforts to steal intellectual property, corporate secrets, and military intelligence.
A U.N. Declaration on Ending AIDS Should Have Been Easy. It Wasn’t.
Even with U.N.’s previous goals unmet, delegates tried to water down provisions regarding protections for vulnerable populations and patents for essential drugs.
Biden Confronts Coronavirus Vaccine Patents
President Biden and drugmakers are facing demands from liberal activists and global leaders to suspend intellectual property rights on the vaccines as the pandemic surges.